FIELD: medicine, anesthesiology, resuscitation.
SUBSTANCE: during the period of controlled reperfusion it is necessary to additionally introduce the solution of Perlinganite preparation at the concentration of 1 mg/ml at the rate of 72 ml/h into hot-shot main line of the artificial circulation apparatus. The innovation provides efficient reconstruction of myocardial function due to coronary vasodilation and steady distribution of heated blood in myocardium.
EFFECT: higher efficiency.
1 ex, 2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREVENTING REPERFUSION MYOCARDIAL DAMAGE IN CONGENITAL HEART DISEASE SURGERY | 2019 |
|
RU2718308C1 |
| METHOD FOR CARDIOPLEGIC ARREST (VERSIONS) | 2015 |
|
RU2571058C1 |
| METHOD OF CARDIOPLEGIC ANTEGRADE MYOCARDIAL PROTECTION | 2022 |
|
RU2803867C1 |
| METHOD FOR MYOCARDIUM PROTECTION AGAINST REPERFUSION INJURIES IN HEART OPERATIONS (EMBODIMENTS) | 2019 |
|
RU2723509C1 |
| METHOD OF CARRYING OUT CARDIOPLEGIA | 2009 |
|
RU2434589C2 |
| METHOD OF SURGICAL TREATMENT OF CORONARY HEART DISEASE | 2022 |
|
RU2802555C1 |
| METHOD FOR PREVENTION OF HEART RHYTHM DISORDER IN CARDIAC SURGERIES | 2011 |
|
RU2467754C2 |
| METHOD FOR TREATING ACUTE MYOCARDIAL INFARCTION CASES | 2004 |
|
RU2267323C1 |
| METHOD OF OPERATIVE MYOCARDIUM PROTECTION USING ARTIFICIAL CIRCULATION | 2006 |
|
RU2330663C2 |
| CARDIOPLEGIC SOLUTION (VERSIONS) | 2014 |
|
RU2574957C1 |
